These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7636876)

  • 1. (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses.
    Chenard BL; Bordner J; Butler TW; Chambers LK; Collins MA; De Costa DL; Ducat MF; Dumont ML; Fox CB; Mena EE
    J Med Chem; 1995 Aug; 38(16):3138-45. PubMed ID: 7636876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (3R,4S)-3-[4-(4-fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: a conformationally restricted analogue of the NR2B subtype-selective NMDA antagonist (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)- 1-propanol.
    Butler TW; Blake JF; Bordner J; Butler P; Chenard BL; Collins MA; DeCosta D; Ducat MJ; Eisenhard ME; Menniti FS; Pagnozzi MJ; Sands SB; Segelstein BE; Volberg W; White WF; Zhao D
    J Med Chem; 1998 Mar; 41(7):1172-84. PubMed ID: 9544217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents.
    Menniti FS; Pagnozzi MJ; Butler P; Chenard BL; Jaw-Tsai SS; Frost White W
    Neuropharmacology; 2000 Apr; 39(7):1147-55. PubMed ID: 10760358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CP-101,606, a potent neuroprotectant selective for forebrain neurons.
    Menniti F; Chenard B; Collins M; Ducat M; Shalaby I; White F
    Eur J Pharmacol; 1997 Jul; 331(2-3):117-26. PubMed ID: 9274969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (+/-)-3-(4-hydroxyphenyl)pyrrolidines: selective antagonists at the 1A/2B NMDA receptor subtype.
    Guzikowski AP; Tamiz AP; Acosta-Burruel M; Hong-Bae S; Cai SX; Hawkinson JE; Keana JF; Kesten SR; Shipp CT; Tran M; Whittemore ER; Woodward RM; Wright JL; Zhou ZL
    J Med Chem; 2000 Mar; 43(5):984-94. PubMed ID: 10715162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture.
    Shalaby IA; Chenard BL; Prochniak MA; Butler TW
    J Pharmacol Exp Ther; 1992 Feb; 260(2):925-32. PubMed ID: 1346650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist.
    Zhou ZL; Cai SX; Whittemore ER; Konkoy CS; Espitia SA; Tran M; Rock DM; Coughenour LL; Hawkinson JE; Boxer PA; Bigge CF; Wise LD; Weber E; Woodward RM; Keana JF
    J Med Chem; 1999 Jul; 42(15):2993-3000. PubMed ID: 10425109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds.
    Chenard BL; Shalaby IA; Koe BK; Ronau RT; Butler TW; Prochniak MA; Schmidt AW; Fox CB
    J Med Chem; 1991 Oct; 34(10):3085-90. PubMed ID: 1681106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade by ifenprodil of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions.
    Church J; Fletcher EJ; Baxter K; MacDonald JF
    Br J Pharmacol; 1994 Oct; 113(2):499-507. PubMed ID: 7834201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-selective antagonism of NMDA receptors by nylidrin.
    Whittemore ER; Ilyin VI; Konkoy CS; Woodward RM
    Eur J Pharmacol; 1997 Oct; 337(2-3):197-208. PubMed ID: 9430414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
    Carter CJ; Lloyd KG; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade by sigma site ligands of N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurones.
    Fletcher EJ; Church J; Abdel-Hamid K; MacDonald JF
    Br J Pharmacol; 1995 Dec; 116(7):2791-800. PubMed ID: 8680708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro.
    Murray F; Kennedy J; Hutson PH; Elliot J; Huscroft I; Mohnen K; Russell MG; Grimwood S
    Eur J Pharmacol; 2000 Jun; 397(2-3):263-70. PubMed ID: 10844123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade by polyamine NMDA antagonists related to ifenprodil of NMDA-induced synthesis of cyclic GMP, increases in calcium and cytotoxicity in cultured neurones.
    Beart PM; Schousboe A; Frandsen A
    Br J Pharmacol; 1995 Apr; 114(7):1359-64. PubMed ID: 7606339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomer.
    Ornstein PL; Schoepp DD; Arnold MB; Jones ND; Deeter JB; Lodge D; Leander JD
    J Med Chem; 1992 Aug; 35(17):3111-5. PubMed ID: 1387167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones.
    Kew JN; Kemp JA
    J Physiol; 1998 Oct; 512 ( Pt 1)(Pt 1):17-28. PubMed ID: 9729614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
    Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
    J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of the anti-ischemic agent ifenprodil on N-methyl-D-aspartate and kainate-mediated excitotoxicity.
    Zeevalk GD; Nicklas WJ
    Brain Res; 1990 Jul; 522(1):135-9. PubMed ID: 1977493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action.
    Ornstein PL; Schoepp DD; Arnold MB; Leander JD; Lodge D; Paschal JW; Elzey T
    J Med Chem; 1991 Jan; 34(1):90-7. PubMed ID: 1825117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.